medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2014, Number 3

<< Back Next >>

Acta Pediatr Mex 2014; 35 (3)

Psychological evaluation of applicants accepted into Pediatrics Residency Program at Instituto Nacional de Pediatría

Bustamante-Ogando JC, Rosas-Vargas R, Barcelata-Eguiarte B, Vázquez-Rivera M, Espinosa-Garamendi E

Language: Spanish
References: 29
Page: 202-211
PDF size: 692.17 Kb.


ABSTRACT

In order to select the best candidates for pediatric residency program, it is important to consider not only academic skills but also the features of cognitive and personality profile to reassure an optimal performance. The aim of this study was to describe the psychological profile of physicians accepted for Pediatric Residency Program at Instituto Nacional de Pediatría. With a descriptive, transversal, retrospective design, data were obtained from 44 files of accepted physicians, where cognitive reaccioand personality assessment was obtained from 2 psychometric scales: DAT-5 and MMPI-2.

Residents profile included logic and common sense, fast response, work under pressure and teamwork abilities. However, they frequently scored low on empathy, moral conscience, showed difficulties for hard work, frustration tolerance, and poor ego strength. Further research is needed including a cohort design, in order to determinate the ideal profile for pediatrician resident admission. The selection is based mainly in medical knowledge evaluation, but it is needed to know about psychological strengths and weakness with the aim of establishing programs focused in this area, allowing better performance during pediatric residency program.


REFERENCES

  1. Guyton AC, Hall JE. Tratado de fisiología médica. 11 Edición. 2006, Ed. Elsevier. pp. 204-240.

  2. Widmaier E, Raff H, Strang K. Vander’s Human Physiology, 11th Ed. McGraw-Hill. 2008. pp. 291, 509–10.

  3. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute. Report of the Second Task Force on Blood Pressure Control in Children. Pediatrics 1987;79:1–25.

  4. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555–76.

  5. Avner DE, Harmon WE, Niaudet P, Yoshikawa N. Pediatric Nephrology. 2009. Sixth Edition. Springer. pp. 1482-1576.

  6. Gomes RS, Quirino IG, Pereira RM, Vitor BM, Leite AF, Oliveira EA, et al. Primary versus secondary hypertension in children followed up at an outpatient tertiary unit. Pediatr Nephrol 2011;26:441–447.

  7. Lagomarsino E, Saieh C, Aglony M. Recomendación de Ramas: Actualizaciones en el diagnóstico y tratamiento de la Hipertensión Arterial en Pediatría. Rama de Nefrología, Sociedad Chilena de Pediatría. Rev Chil Pediatr 2008;79:63- 81.

  8. Falkner B. Hypertension in children and adolescents: epidemiology and natural history. Pediatr Nephrol. 2010;25:1219–1224.

  9. Kanbay M, et al. Causes and Mechanisms of Nondipping Hypertension. Clinical an Experimental Hypertension 2008;30:585-597.

  10. Wesson DE. Hypertension and the Kidney. Curr Hypertens Rep 2001;3:511-6.

  11. Mitsnefes MM, Omoloja A, McEnery PT. Short-term pediatric renal transplant survival: blood pressure and allograft function. Pediatr Transplant 2001;5:160–165.

  12. Goto M, Hoxha N, Osman R, Dell KM. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease. Pediatr Nephrol 2010;25:2449–2457.

  13. Borrajato E, Gutiérrez A, López L, Tacons J. Hipertensión arterial de origen endocrino. Sociedad Española de Endocrinología Pediátrica. Disponible en: http://www.seep.es/ privado/download.asp?url=consenso/cap30.pdf

  14. Lande MB, Flynn JT. Treatment of hypertension in children and adolescents. Pediatr Nephrol 2009;10:1939-49.

  15. Hernández Avendaño L. Nefrología clínica. 3ª Ed. España: Médica Panamericana; 2009.

  16. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 suppl 4th report):555–576.

  17. Silverstein DM, Champoux E, Aviles DH, Vehaskari VM. Treatment of primary and secondary hypertension in children. Pediatr Nephrol 2006;21:820–827.

  18. Woroniecki RP, Flynn JT. How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists. Pediatr Nephrol 2005;20:791– 797.

  19. Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles. Am J Med 1973;55:261-274.

  20. Laragh JH, Sealey JE, Niarchos AP, Pickering TG. The vasoconstriction-volum spectrum in normotension an the pathogenesis of hypertension. Fed Proc 1982;41:2415-23.

  21. Laragh JH. Laragh´s Lessons in Pathophysiology and Clinical Pearls for Treating Hypertension. Lesson XV: The volumevasoconstriction equation that supports all normotension and hypertension. Amer J Hypertens 2001;14:397-404.

  22. Laragh JH. Laragh´s Lessons in Pathophysiology and Clinical Pearls for Treating Hypertension. Lesson XVI: How to choose the correct drug for each hypertensive patient using a plasma rennin-based method and the volume vasoconstriction analysis. Amer J Hypertens 2001;14:491-503.

  23. Laragh JH. The Laragh Method for correcting the BP of patients with uncontrolled hypertension. Disponible en: http://laraghmethod.org

  24. Sealey JE, Parra D, Rosenstein R, Laragh JH. Effective” plasma renin activity: a derived measure for assessing residual plasma renin activity in patients taking angiotensin- converting enzyme inhibitors or angiotensin receptor blockers. Hypertension 2010;55(3):e16.

  25. Egan BM, Basile JN, Rehman SU, Davis PB, Grob CH 3rd, Riehle JF, et al. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens 2009;22(7):792-801.

  26. Leotta G, Rabbia F, Testa E, Totaro S, Abram S, Milan A, et al. Efficacy of antihypertensive treatment based on plasma rennin activity: An open label observational study. Blood Press 2010;19(4):218-24.

  27. Méndez RI, Namihira GD, Moreno AL y Sosa de Martínez C. El Protocolo de Investigación: Lineamientos para su Elaboración y Análisis, 2a Edición, Ed. Trillas, 2004.

  28. Zaltzman S, Miranda E, García de la Puente S, Murata C. Hipertensión arterial en pediatría. Acta Pediátrica de Médica de México 2012;33.

  29. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test, Statistic in Medicine 1982;1:121-129.




2020     |     www.medigraphic.com